DE69831348D1 - Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii -metallverbindungen - Google Patents

Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii -metallverbindungen

Info

Publication number
DE69831348D1
DE69831348D1 DE69831348T DE69831348T DE69831348D1 DE 69831348 D1 DE69831348 D1 DE 69831348D1 DE 69831348 T DE69831348 T DE 69831348T DE 69831348 T DE69831348 T DE 69831348T DE 69831348 D1 DE69831348 D1 DE 69831348D1
Authority
DE
Germany
Prior art keywords
gallenous
bloodcholesterine
deflection
iii
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831348T
Other languages
English (en)
Other versions
DE69831348T2 (de
Inventor
Roy Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Publication of DE69831348D1 publication Critical patent/DE69831348D1/de
Application granted granted Critical
Publication of DE69831348T2 publication Critical patent/DE69831348T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69831348T 1997-11-26 1998-11-18 Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii -metallverbindungen Expired - Lifetime DE69831348T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724840.5A GB9724840D0 (en) 1997-11-26 1997-11-26 Reduced blood cholesterol
GB9724840 1997-11-26
PCT/GB1998/003475 WO1999026638A1 (en) 1997-11-26 1998-11-18 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances

Publications (2)

Publication Number Publication Date
DE69831348D1 true DE69831348D1 (de) 2005-09-29
DE69831348T2 DE69831348T2 (de) 2006-06-22

Family

ID=10822574

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831348T Expired - Lifetime DE69831348T2 (de) 1997-11-26 1998-11-18 Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii -metallverbindungen

Country Status (7)

Country Link
EP (1) EP1032406B1 (de)
JP (1) JP2001523725A (de)
AT (1) ATE302609T1 (de)
DE (1) DE69831348T2 (de)
ES (1) ES2247725T3 (de)
GB (1) GB9724840D0 (de)
WO (1) WO1999026638A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
DE69413544T2 (de) * 1993-08-24 1999-05-27 Kappa Pharmaceuticals Ltd., Reading Reduzierte absorption von fettsäuren

Also Published As

Publication number Publication date
EP1032406A1 (de) 2000-09-06
EP1032406B1 (de) 2005-08-24
GB9724840D0 (en) 1998-01-21
ES2247725T3 (es) 2006-03-01
DE69831348T2 (de) 2006-06-22
JP2001523725A (ja) 2001-11-27
WO1999026638A1 (en) 1999-06-03
ATE302609T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
WO2000078344A8 (en) Prion protein peptides and uses thereof
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
GB2335599B (en) Membrane-bound receptors and their function; cognitive disfunction; treatments therefor; and compositions for use in such treatments
HK1026030A1 (en) Display plate for timepieces and method for fabricating the same.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
EP0911039A3 (de) Wirkstoff-Harzkomplexe stabilisiert mit Chelatbildner
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE69525747D1 (de) Implantierbare kapsel zur hervorhebung der zellpotentiale
NZ288883A (en) Conjugates comprising coagulation factors
NZ335799A (en) Improvements in or relating to diagnostic/therapeutic agents
DE69719360D1 (de) Zusammensetzungen und methoden zur steigerung der darmfunktion
HK1062636A1 (en) Combination therapy
ATE211135T1 (de) Aminocyclohexylester und ihre anwendung
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
AU4584901A (en) Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
AU1280002A (en) Composite panel for repairing, reinforcing con'c body and method of using the same
EP1604674A3 (de) Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz
HK1032106A1 (en) Combined pickoff and oscillatory driver for use incoriolis flowmeters and method of operating the same.
NO994233D0 (no) Sterol-estere i faste, tabletterte doseringsformer
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
DE69831348D1 (de) Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii -metallverbindungen
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
AU6849198A (en) Neurotrypsin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GRAMM, LINS & PARTNER GBR, 30173 HANNOVER